Cargando…

Microablative Erbium: YAG Laser Therapy for Vulvodynia – A Report on Efficacy, Safety, and Treatment Satisfaction

INTRODUCTION: Treatment for vulvodynia is challenging and a multidisciplinary approach is recommended. AIM: To examine the effectiveness, safety and treatment satisfaction of vulvovaginal microablative laser treatment for vulvodynia. METHODS: Case study of women who received laser treatment as part...

Descripción completa

Detalles Bibliográficos
Autores principales: Trutnovsky, Gerda, Bliem, Brigitte, Greimel, Elfriede, Tamussino, Karl, Gold, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766257/
https://www.ncbi.nlm.nih.gov/pubmed/34551383
http://dx.doi.org/10.1016/j.esxm.2021.100432
Descripción
Sumario:INTRODUCTION: Treatment for vulvodynia is challenging and a multidisciplinary approach is recommended. AIM: To examine the effectiveness, safety and treatment satisfaction of vulvovaginal microablative laser treatment for vulvodynia. METHODS: Case study of women who received laser treatment as part of a multidisciplinary treatment program for vulvodynia. Subjective improvement was compared to a retrospective cohort of women treated for vulvodynia without LASER therapy. LASER treatment was offered to women with vulvodynia presenting to a gynecologic pain clinic of a tertiary university hospital. LASER treatments were performed with a microablative 2,940 nm Er:YAG LASER and potentially repeated after 1 month. MAIN OUTCOME MEASURES: Change in local vulvar pain was assessed with cotton-swab tests and rated on a numeric rating scale (NRS). Treatment discomfort and short-term adverse events were recorded. The Freiburg Index of Patient Satisfaction was used to assess treatment satisfaction. Subjective symptom improvement was assessed with the Patient Global Impression of Improvement questionnaire. RESULTS: 35 women received at least 1 laser treatment, with overall mild treatment adverse effects (mean pain NRS 2.4 [Formula: see text] 1.9) and good treatment satisfaction (mean total score of 27.6 [Formula: see text] 5.1; potential range 8–32). One month after last LASER treatment the pain NRS on vulvar cotton swab test improved from 6.1 [Formula: see text] 2.6 at baseline to 3.1 [Formula: see text] 2.6 (P < .001), and 74% of women (n = 26) reported symptom improvement. At 9–12 months follow-up 66% reported ongoing symptom improvement, with no significant difference to the control group of 32 women. CONCLUSION: Microablative Er:YAG vulvovaginal LASER therapy appears safe and well accepted among vulvodynia patients, but there was no significant difference in symptom improvement compared to a control group. Trutnovsky G, Bliem B, Greimel E, et al. Microablative Erbium: YAG Laser Therapy for Vulvodynia – A Report on Efficacy, Safety, and Treatment Satisfaction. Sex Med 2021;9:100432.